SEC Form 4 · accession 0001363213-16-000074
SCICLONE PHARMACEUTICALS INC · SCLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Friedhelm Blobel
Officer — President & CEO · Director
Period of report
Apr 11, 2016
Accepted (ET)
Apr 13, 2016 · 10:55 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880771
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 11, 2016 | M | 160,640 | $2.49 | A | 365,892 | D | |
| Common Stock | Apr 11, 2016 | F | 99,260 | $12.39 | D | 266,632 | D | |
| Common Stock | Apr 11, 2016 | M | 499,160 | $2.49 | A | 765,792 | D | |
| Common Stock | Apr 11, 2016 | F | 306,510 | $12.39 | D | 459,282 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F2,F3 | $2.49 | Apr 11, 2016 | M | 160,640 | D | — | Jun 2, 2016 | Common Stock | 160,640 | 0 | D |
| Non-Qualified Stock Option (right to buy)F2,F4 | $2.49 | Apr 11, 2016 | M | 499,160 | D | — | Jun 2, 2016 | Common Stock | 499,160 | 0 | D |
Explanation of responses
- F1Shares disposed represent shares withheld to cover withholding tax obligations and the exercise price in connection with the exercise of the options.
- F2Granted under the Issuer's 2005 Equity Incentive Plan.
- F3Provided the reporting person remains employed by or acting as a consultant to the Company, the option will become exercisable in four equal annual installments on 6/02/07, 6/02/08, 6/02/09 and 6/02/10.
- F41/36th of the outstanding options shall vest monthly over a three year period, with initial vesting occurring on June 1, 2010.